Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin typesCapsule Summary

• Main Authors: Angela L. Bosma, MD (Author), Wouter Ouwerkerk, PhD (Author), Madeline J. Heidema, MD (Author), David Prieto-Merino, PhD (Author), Michael R. Ardern-Jones, MD, PhD (Author), Paula Beattie, MD (Author), Sara J. Brown, MD, PhD (Author), John R. Ingram, MD, PhD (Author), Alan D. Irvine, MD, DSc (Author), Graham Ogg, MD, PhD (Author), Prakash Patel, BSc (Author), Nick J. Reynolds, MD, PhD (Author), R.M. Ross Hearn, MD (Author), Mandy Wan, PhD (Author), Richard B. Warren, MD, PhD (Author), Richard T. Woolf, MD, PhD (Author), Ariënna M. Hyseni (Author), Louise A.A. Gerbens, MD, PhD (Author), Phyllis I. Spuls, MD, PhD (Author), Carsten Flohr, MD, PhD (Author), Maritza A. Middelkamp-Hup, MD, PhD (Author)
• Format: Book
• Published: Elsevier, 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Few data exist on differences in treatment effectiveness and safety in atopic dermatitis patients of different skin types. Objective: To investigate treatment outcomes of dupilumab, methotrexate, and ciclosporin, and morphological phenotypes in atopic dermatitis patients, stratified by F...